New Liquid Biopsy Product Launches to Boost Market Revenues
More players will launch new products during the forecast period, which will increase the sales and sustain market growth, says RNCOS.
According to a new research report by RNCOS entitled, "Global Liquid Biopsy Market Outlook 2020", there is an increasing trend of new product development, along with high levels of marketing support. This trend often helps in increasing the overall demand for the product in the market. Thus, several players are currently launching new diagnostic solutions to expand their product portfolios. Moreover, this trend has become predominant even in the field of circulating tumor cells, which initially focused on cell enumeration for prognosis purposes.
Diagnostic companies in the liquid biopsy market have responded to this need by undertaking technological approaches to develop these diagnostics tests for an array of applications and cancer types. Many diagnostic companies of various sizes and capabilities have also recently entered the biopsy field, pursuing novel technologies or setting ambitious goals such as the diagnosis of all cancer types at early stages.
Oncology is the major application area for which majority of the clinical trials is being conducted followed by the prenatal screening, and organ transplantation. Oncology is expected to account for the largest share in the liquid biopsy application market.
Most of the current research is focused on utilizing liquid biopsy for diagnostic purposes such as response evaluation, expression profiling, tumor diagnosis and treatment monitoring in a blood test.
Numerous Liquid biopsy players such as Biocept, NeoGenomics, Biocartis, Pathway Genomics, are offering liquid biopsy based services using their proprietary technologies. Since research in this field has been garnering a lot of interest due to the wide applicability of liquid biopsy, the market is expected to continue to grow at the double digit rate of 18.1% for the next five years.
Research Analysis and Highlights
The report provides an in-depth research and rational analysis of the current status and future prospect of the Global Liquid Biopsy Market Outlook 2020. The study presents a transparent picture about the current and future market outlook, in terms of the sample type, technology and geography. The report also provides a comprehensive insight about the market dynamics including the drivers, challenges, opportunities, and upcoming trends that would influence the market.
The report also covers detailed information about key players in the global liquid biopsy market, to enable the clients to understand the market structure and its growth during the forecasted period. In brief, the report, "Global Liquid Biopsy Market Outlook 2020", covers all the necessary aspects of the global liquid biopsy market, providing an in-depth research and prudent analysis of the key segments.
Some of the key highlights of the report include the following:
• Growth drivers such as increasing prevalence of Cancer; increasing demand for minimally-invasive biopsy techniques; low cost and growing investment for liquid biopsy market.
• Holistic view of the liquid biopsy market, segmentation in terms of the sample type, the technology, pipeline analysis and the regional prevalence.
• Leading players and their product portfolio in the liquid biopsy market.
For FREE SAMPLE of this report visit: http://rncos.viewpage.co/Global-Liquid-Biopsy-Market-Outlook-to-2020
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
by: Shushmul Maheshwari